Skip to main content

Breadcrumb

  1. Home

Renal

Renal

The Renal Standing Committee oversees the consensus based entity's portfolio of renal measures, which includes measures for hemodialysis, standardized mortality and transfusion ratios, phosphorus concentration, hypercalcemia, pediatric hemodialysis, Angiotensin Converting Enzyme  Inhibitor or Angiotensin Receptor Blocker therapy, optimal end stage renal disease starts, and bloodstream infections in hemodialysis patients.

Measures

Project

Measures

Final Reports

Media

Final Reports

Materials

Materials

Materials

Material File Material Type Cycle
Fall-2022-Renal-Post-Comment-Slides-508.pdf Presentation slides Fall 2022
Renal-Fall-2022-Final-Project-Report.pdf Final Report Fall 2022
Fall-2022-Renal-Post-Comment-Meeting-Summary.pdf Meeting summary Fall 2022
Post-Comment-Developer-Responses-Renal-Fall-2022.xlsx Developer responses to comments Fall 2022
Fall-2022-Renal-Post-Comment-Agenda-508.pdf Agenda Fall 2022
Fall-2022-Renal-Post-Comment-Memo-508.pdf Memo Fall 2022